Insider Shareholders with Direct Ownership of Relmada Therapeutics, Inc. (RLMD)
This section provides a comprehensive overview of the insiders with direct ownership of Relmada Therapeutics, Inc. (RLMD). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
RELMADA THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sergio Traversa
Chief Executive Officer |
388,298 | 79,767 | 384,024 $138,248 | 31 |
Sep 11, 2024
Added 11.81%
|
|
Paul Edward Kelly
Director |
80,000 | 55,000 | 212,295 $76,426 | 21 |
Sep 09, 2024
Added 10.54%
|
|
Maged Shenouda
Chief Financial Officer |
122,107 | 36,000 | 88,335 $31,800 | 27 |
Sep 11, 2024
Added 21.45%
|
|
Chuck Ence
CA and CO |
38,970 | 0 | 38,970 $14,029 | 3 |
Jan 31, 2024
Added 25.97%
|
|
Cedric O'Gorman
Chief Medical Officer |
10,000 | 0 | 10,121 $3,643 | 1 |
May 23, 2023
Added 49.7%
|
|
Charles J Casamento
Director |
52,800 | 90,923 | 0 $0 | 18 |
Oct 22, 2024
Reduced 100.0%
|